No abstract available
MeSH terms
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / economics*
-
Antineoplastic Agents / therapeutic use
-
Benzamides
-
Breast Neoplasms / drug therapy
-
Cost-Benefit Analysis
-
Drug Costs
-
Female
-
Health Care Costs
-
Humans
-
Imatinib Mesylate
-
Lung Neoplasms / drug therapy
-
Male
-
Piperazines / economics
-
Piperazines / therapeutic use
-
Prostatic Neoplasms / drug therapy
-
Protein Kinase Inhibitors / economics
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrimidines / economics
-
Pyrimidines / therapeutic use
-
Trastuzumab
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
Trastuzumab